To investigate whether PTPRO contributes to steatosis and tumorigenesis, we used a NASH-HCC animal model to monitor progression from obesity to HCC according to the method reported by Park [24]. The gene discussed is PTPRO; the disease is metabolic dysfunction-associated steatohepatitis.